Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LYOPHILIZED VIALS OF VCA AND VCAT

K-Number: K780306 · 1978-03-17

ApplicantGibco Laboratories Life Technologies, Inc.
Decision Date1978-03-17
Product CodeJSK
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

LYOPHILIZED VIALS OF VCA AND VCAT is the device name listed in this FDA 510(k) record. The listed applicant is Gibco Laboratories Life Technologies, Inc.. It received FDA 510(k) clearance on 1978-03-17 under 510(k) number K780306. The device is classified under product code JSK. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LYOPHILIZED VIALS OF VCA AND VCAT?

LYOPHILIZED VIALS OF VCA AND VCAT is a medical device that received FDA 510(k) clearance on 1978-03-17. The listed applicant is Gibco Laboratories Life Technologies, Inc.. The 510(k) number is K780306.

When did LYOPHILIZED VIALS OF VCA AND VCAT receive FDA 510(k) clearance?

LYOPHILIZED VIALS OF VCA AND VCAT received FDA 510(k) clearance on 1978-03-17, under 510(k) number K780306.

Who is the listed applicant for LYOPHILIZED VIALS OF VCA AND VCAT?

The FDA 510(k) record lists Gibco Laboratories Life Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LYOPHILIZED VIALS OF VCA AND VCAT?

The FDA product code for LYOPHILIZED VIALS OF VCA AND VCAT is JSK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Gibco Laboratories Life Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K871855SORBITOL MACCONKEY (SMAC) AGAR, DRI & PRE-FORMK871541MARTIN-LEWIS AGAR W/REDUCED VANCOMYCIN C0226K870134MCBRIDE LISTERIA AGAR W/CYCLOHEXIMIDE, DRI & PREK864755PSEUDOMONAS CEPACIA SELECTIVE AGAR, DRI & PRE-FORMK864014LOMBARD DOWELL AGAR BASEK863821MUELLER HINTON AGAR W/4%NACL AND OXACILLIN

View all 67 devices →

Related Devices (Code: JSK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K881949ATS NAC-PAC SETAlpha-Tec Systems, Inc.K881879ATS M/15 PHOSPHATE BUFFER, PRODUCT #034-42Alpha-Tec Systems, Inc.K881566HEMOGLOBIN POWDERAcumedia Manufacturers, Inc.K861997PENICILLIN-STREPTOMYCIN-FUNGIZONE MIXTUREHazleton Research Products, Inc.K861791PENICILLIN-STREPTOMYCIN-FUNGIZONEFlow Laboratories, Inc.K861824GENTAMICIN SULFATE SOLUTION (10MG GENTAMICIN)Flow Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑